IP Library Patent Application 11493589
Patent Application
App. No. 11/493,589

Dermatological compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/493,589
Filed
Jul 27, 2006
Art Unit
1611
USPC
514/588
Abstract

Topical dermatological compositions comprising urea as an active ingredient, a vegetable oil or a derivative thereof, water, and conventional excipients. These compositions are used for topical medical applications, particularly to treat various skin disorders.

Claims (43)

1 . A dermatological composition suitable for topical administration comprising:

about 5 to about 60% by weight of an active ingredient consisting of urea;

about 3 to about 45% by weight of a vegetable oil or a derivative thereof;

water; and

remaining amounts of one or more dermatologically acceptable agents.

2 . The dermatological composition of claim 1 , comprising about 30 to about 60% by weight of said active ingredient and about 3 to about 20% by weight of said vegetable oil or derivative thereof.

3 . The dermatological composition of claim 1 , comprising about 40 to about 55% by weight of said active ingredient and about 5 to about 15% by weight of said vegetable oil or derivative thereof.

4 . The dermatological composition of claim 1 , wherein said composition has a pH of about 3 to about 11.

5 . The dermatological composition of claim 4 , wherein said composition has a pH of about 5 to about 10.5.

6 . The dermatological composition of claim 5 , wherein said composition has a pH of about 7 to about 10.

7 . The dermatological composition of claim 1 , wherein said composition is an emulsion having an oil phase and an aqueous phase.

8 . The dermatological composition of claim 7 , formulated as an oil-in-water emulsion.

9 . The dermatological composition of claim 7 , wherein said vegetable oil or derivative thereof is present in said oil phase and is selected from the group consisting of castor oil, sunflower oil, a liquid fraction of karite butter, cottonseed oil, canola oil, corn oil, hydrogenated vegetable oil, peanut oil, sesame oil, soybean oil, palm oil, coconut oil, rapeseed oil, safflower oil, cocoa butter, linseed oil, olive oil, almond oil, avocado oil, citrus seed oil, cohune oil, tallow, oat oil, palm kernel oil, rice bran oil, tucum oil, babassu oil, derivatives thereof, and mixtures thereof.

10 . The dermatological composition of claim 7 , wherein said dermatologically acceptable agents are selected from the group consisting of emulsifiers, surfactants, suspending agents, antioxidants, chelates, emollients, humectants, fluid alkyl alcohols, thickening agents, polysiloxanes, modified polysiloxanes, pH modifiers, and mixtures thereof.

11 . The dermatological composition of claim 10 , wherein said emulsion is formed using an emulsifier selected from the group consisting of straight or branched chain fatty acids, polyoxyethylene sorbitan fatty acid esters, sorbitan fatty acid esters, propylene glycol stearate, glyceryl stearate, polyethylene glycol, fatty alcohols, polymeric ethylene oxide-propylene oxide block polymers, derivatives thereof, pharmaceutically acceptable salts thereof, and mixtures thereof.

12 . The dermatological composition of claim 11 , wherein said emulsifier is present in a phase of said emulsion selected from the group consisting of said oil phase, said aqueous phase, and a combination thereof.

13 . The dermatological composition of claim 10 , wherein said surfactant is selected from the group consisting of a nonionic surfactant, an anionic surfactant, an amphoteric surfactant, a cationic surfactant, and mixtures thereof.

14 . The dermatological composition of claim 10 , comprising at least two surfactants.

15 . The dermatological composition of claim 10 , wherein said suspending agent and said surfactant are present in a phase of said emulsion selected from the group consisting of said oil phase, said aqueous phase, and a combination thereof.

16 . The dermatological composition of claim 1 , comprising about 5 to about 90% by weight of water.

17 . The dermatological composition of claim 7 , wherein said urea is present in said aqueous phase or said oil phase.

18 . The dermatological composition of claim 1 , wherein said composition is in a lotion, cream, ointment, shampoo, gel, aerosol, solution, paste, suspension, skin cleanser, bar, or other pharmaceutically acceptable topical dosage form.

19 . A method of treating a skin disorder in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 1 .

20 . The method of claim 19 , wherein said skin disorder is selected from the group consisting of cracked skin, disturbed barrier function, dry skin, eczema, icthyotic atopic eczema, acthyotic skin, subacute and chronic atopic eczema, xerosis, rough skin, dermatitis, psoriasis, ichthyosis, keratosis, keratoderma, corns, calluses, scales, nummular dermatitis, lichen simplex chronicus, pityriasis rosea, dandruff, acne, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, hyperkeratotic skin, inflammatory dermatoses, skin changes associated with aging, skin requiring cleansers, and combinations thereof.

21 . The method of claim 19 , wherein said topical administration moisturizes said skin.

22 . The method of claim 19 , wherein said method improves moisture content of said skin.

23 . A method of treating or preventing dry skin in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 1 .

24 . The method of claim 23 , wherein said topical administration moisturizes said skin.

25 . A dermatological composition suitable for topical administration comprising an oil-in-water emulsion comprising:

an oil phase comprising about 3 to about 20% by weight of the overall weight of the composition of a vegetable oil or a derivative thereof and at least one emulsifier; and

an aqueous phase comprising about 30 to about 60% by weight of the overall weight of the composition of an active ingredient consisting of urea and about 15 to about 55% by weight of the overall weight of the composition of water,

wherein said emulsion further comprises at least two surfactants and at least one suspending agent present in a phase of said emulsion selected from the group consisting of said oil phase, said aqueous phase, and a combination thereof, and wherein said dermatological composition has a pH of from about 3 to about 11.

26 . The dermatological composition of claim 25 , comprising about 45 to about 55% by weight of said active ingredient and about 5 to about 10 by weight of said vegetable oil or derivative thereof.

27 . The dermatological composition of claim 25 , wherein said composition has a pH of about 7 to about 10.

28 . A method of treating a skin disorder in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 25 .

29 . A method of treating or preventing dry skin in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 25 .

30 . A dermatological composition suitable for topical administration comprising an oil-in-water emulsion comprising:

an oil phase comprising about 15 to about 45% by weight of the overall weight of the composition of a vegetable oil or a derivative thereof and at least one emulsifier; and

an aqueous phase comprising about 40 to about 55% by weight of the overall weight of the composition of an active ingredient consisting of urea and about 25 to about 40% by weight of the overall weight of the composition of water,

wherein said emulsion further comprises at least two surfactants and at least one suspending agent present in a phase of said emulsion selected from the group consisting of said oil phase, said aqueous phase, and a combination thereof, and wherein said dermatological composition has a pH of from about 3 to about 11.

31 . The dermatological composition of claim 30 , comprising about 47 to about 53% by weight of said active ingredient and about 5 to about 10% by weight of said vegetable oil or derivative thereof.

32 . A method of treating a skin disorder in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 30 .

33 . A method of treating or preventing dry skin in a mammal, comprising topically administering to skin of a mammal in need thereof a therapeutically effective amount of the dermatological composition of claim 30.

Assignments (7)
RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT Recorded Aug 26, 2008
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: CONNETICS CORPORATION; STIEFEL LABORATORIES, INC.
Reel/Frame 021439/0259 →
RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT Recorded Aug 26, 2008
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: CONNETICS CORPORATION; STIEFEL LABORATORIES, INC.
Reel/Frame 021439/0201 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Mar 5, 2007
From: STIEFEL LABORATORIES, INC.; CONNETICS CORPORATION
To: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT
Reel/Frame 018961/0012 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Mar 2, 2007
From: STIEFEL LABORATORIES, INC.; CONNETICS CORPORATION
To: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT
Reel/Frame 018951/0380 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Jan 30, 2007
From: STIEFEL LABORATORIES, INC.; CONNETICS CORPORATION
To: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT
Reel/Frame 018816/0602 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Jan 26, 2007
From: STIEFEL LABORATORIES, INC.; CONNETICS CORPORATION
To: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT
Reel/Frame 018806/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2006
From: POPP, KARL F.; SANTELLI, RONALD J.
To: STIEFEL LABORATORIES, INC
Reel/Frame 018136/0062 →